3-Methoxy-4-(oxazol-5-yl)aniline, 95.0%, 5g

3-Bromo-2-(trifluoromethyl)benzoic acid, 97%, 250mg

1,2,3,4-Tetrahydro-1,6-naphthyridine, 95.0%, 5g

2-Propanol, min 99,5 %, pour synthèse, 10 l, emballage plastique.

Benzoyleneurea, 99.00%, 10g

2-Methyl-5-(4-pentyloxybenzoyl)pyridine, 97.0%, 1g

[(4-methyl-2-propyl-1,3-thiazol-5-yl)methyl]amine hydrochloride, 95.0%, 5g

5-Fluoro-6-(trifluoromethyl)nicotinic acid, 97%, 1g

1-(4-Amino-3-bromophenyl)ethanone, 95.0%, 5g

2-Butoxyquinoline-4-carboxylic acid, 95.0%, 250mg

2,6-Dimethylimidazo[1,2-a]pyridine, 98%, 250mg

2-Fluoro-6-(hydroxymethyl)phenol, 97%, 25g

N-Isopropylaniline, 97.0%, 25g